Astria Biosciences, Inc is a Pittsburgh-based startup company
developing diagnostic and therapeutic solutions
for cerebrovascular disease.
Our work is supported by NSF SBIR Phase I # 2335396
Neuroscience and neurosurgery represent the last true frontiers for mankind.
​
Recent advances in molecular biology, imaging, and diagnostics promise to transform treatment and diagnosis of both neurological and vascular disease.
​
We envision a future where some of the most complex issues in neurosurgery are made routine through the application of advanced molecular biology, high-throughput analysis, and rational approach to discovery in bio-technology.
​
To bring this vision to reality, we are developing a blood-based diagnostic test to detect and risk-stratify cerebral aneurysms as well as molecular-based therapies to combat this disease.
Chief Executive Officer, CTO
Kamil W. Nowicki, MD, PhD
Neurosurgery, Assistant Professor, Columbia University
​
Endovascular Fellowship, '24, Yale​
Neurosurgery Residency, '23, UPMC
Endovascular Fellowship, '21, UPMC
UF College of Medicine, '16, MD, PhD
University of Florida, '08, Chemistry, BS
Economic Analysis
​
Robert Dembinski, BA
General Surgery, Resident, Brown University
​
University of Pittsburgh School of Medicine, '24​
Johns Hopkins University, '20,
BA, Public Health​
Chief Statistical Modeling Analyst
Ali A. Alattar, MD, MAS
Neurosurgery, '25, UPMC
Skullbase Fellowship, '24, UPMC
​
UCSD School of Medicine, '19, MD
UCSD School of Medicine, '19, MAS
Portland State, '14, Biochemistry, BS
Board Member, Business Adviser
Daniel Broderick
Entrepreneur in Residence
University of Pittsburgh
Innovation Institute
​
Iowa State University, BS​
Chief Operations Officer, Treasurer
Aditya Mittal, BS
Medical Student, University of Pittsburgh
NRIF Research Fellow
​​
University of Pittsburgh, '20, Neuroscience, BS
​​
​
Chief Medical Officer
Michael M. McDowell, MD
Neurosurgery, Assistant Professor, UPMC
​
​
Pediatric Neurosurgery, '22, UPMC
Neurosurgery Residency, '21, UPMC
Skullbase Fellowship, '20, UPMC
Columbia College of Surgeons, '14, MD
Arizona State, '09, Biochemistry, BS
Chief Scientific Advisor
Robert M. Friedlander, MD, MA
Neurosurgery, Chairman, UPMC
Distinguished Professor, UPMC
​
Harvard Medical School, '91, MD
Brandeis University, '87, Biochemistry, MA
Brandeis University, '87, Biochemistry, BA
Intern
Rohit Mantena
University of Pittsburgh, '26, Guaranteed BS/MD Program
​
Regeneron STS Top 300 Scholar
National Merit Scholar
Most recent peer-reviewed work
from our academic collaborators
%20(002).png)
